Medtronic

OverviewSuggest Edit

Medtronic manufactures and sells device-based medical therapies. Its products include pacemakers, insertable cardiac monitors, implantable defibrillators, leads and delivery systems, ablation products, electrophysiology catheters, coronary and peripheral stents and related delivery systems, therapies for uncontrolled hypertension, endovascular stent graft systems, heart valve replacement technologies, and cardiac tissue ablation systems. The Company also manufactures image-guided surgery and intra-operative imaging systems.
TypePublic
Founded1949
HQMinneapolis, USMap
Websitemedtronic.com
Employee Ratings3.6More
View Jobs (2,309)

Recent NewsAll News

Latest Updates

Employees (est.) (Apr 2018)86,000(-5%)
Job Openings2,309
Revenue (FY, 2018)$30 B
Share Price (Mar 2019)$91.9 (-2%)

Key People/Management at Medtronic

Omar Ishrak

Omar Ishrak

CEO, Chairman
Karen Parkhill

Karen Parkhill

EVP, CFO
Richard Kuntz

Richard Kuntz

SVP, Chief Medical and Scientific Officer
Carol Surface

Carol Surface

SVP and Chief Human Resources Officer
Michael J. Coyle

Michael J. Coyle

Executive Vice President and President
Alex Gu

Alex Gu

Senior Vice President and President
Show more

Medtronic Office Locations

Medtronic has offices in Minneapolis, Tampa, Sunnyvale, Santa Rosa and in 83 other locations
Minneapolis, US (HQ)
710 Medtronic Pkwy NE
Atlanta, US
Atlanta, GA, USA
Augusta, US
Augusta, GA, USA
Boston, US
Boston, MA, USA
Boulder, US
Boulder, CO, USA
Carlsbad, US
Carlsbad, CA, USA
Show all (95)
Report incorrect company information

Medtronic Financials and Metrics

Medtronic Revenue

Embed Graph
View revenue for all periods
Medtronic's revenue was reported to be $29.95 b in FY, 2018 which is a 0.8% increase from the previous period.
USD

Revenue (Q3, 2019)

7.5b

Gross profit (Q3, 2019)

5.3b

Gross profit margin (Q3, 2019), %

70%

Net income (Q3, 2019)

1.3b

EBIT (Q3, 2019)

1.5b

Market capitalization (18-Mar-2019)

123.2b

Closing stock price (18-Mar-2019)

91.9

Cash (25-Jan-2019)

3.7b

EV

144.6b
Medtronic's current market capitalization is $123.2 b.
Annual
USDFY, 2016FY, 2017FY, 2018

Revenue

28.8b29.7b30.0b

Revenue growth, %

42%3%1%

Cost of goods sold

9.1b9.3b9.1b

Gross profit

19.7b20.4b20.9b
Quarterly
USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Revenue

7.2b7.3b7.3b7.4b7.1b7.4b7.4b7.5b7.5b

Cost of goods sold

2.3b2.3b2.3b2.4b2.1b2.2b2.2b2.2b2.3b

Gross profit

4.9b5.0b5.0b5.0b4.9b5.2b5.2b5.3b5.3b

Gross profit Margin, %

68%68%69%68%70%70%70%71%70%
show all
Annual
USDFY, 2016FY, 2017FY, 2018

Cash

2.9b5.0b3.7b

Accounts Receivable

5.6b5.6b6.0b

Inventories

3.5b3.3b3.6b

Current Assets

23.6b24.9b23.0b
Quarterly
USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Cash

3.1b3.0b2.8b4.7b5.5b6.4b4.4b3.9b3.7b

Accounts Receivable

5.4b5.7b5.5b5.8b5.8b5.8b5.7b5.7b5.9b

Inventories

3.6b3.7b3.7b3.5b3.6b3.8b3.7b3.8b3.9b

Current Assets

23.5b22.5b22.4b24.8b25.2b26.6b22.5b21.7b20.9b
show all
Annual
USDFY, 2016FY, 2017FY, 2018

Net Income

3.5b4.0b3.1b

Depreciation and Amortization

2.8b2.9b2.6b

Inventories

(186.0m)(227.0m)(192.0m)

Accounts Payable

(379.0m)356.0m65.0m
Quarterly
USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Net Income

929.0m2.0b2.9b1.0b3.0b1.6b1.1b2.2b3.5b

Depreciation and Amortization

737.0m1.5b2.2b636.0m1.3b2.0b666.0m1.3b2.0b

Inventories

(101.0m)(187.0m)(261.0m)(164.0m)(273.0m)(318.0m)(180.0m)(312.0m)(367.0m)

Accounts Payable

(298.0m)(306.0m)32.0m(392.0m)(307.0m)13.0m85.0m24.0m211.0m
show all
USDY, 2019

EV/EBIT

93.8 x

EV/CFO

29.4 x

Debt/Equity

0.5 x

Debt/Assets

0.3 x

Financial Leverage

1.8 x
Show all financial metrics

Medtronic Operating Metrics

FY, 2015FY, 2016FY, 2017FY, 2018

Countries

160 160 160 150

Locations

345 224 189 180

Locations (US)

70 12 12 12

Manufacturing Facilities

80 89
Show all operating metrics

Medtronic Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
EPIX TherapeuticsJanuary 29, 2019
NutrinoNovember 30, 2018
Mazor RoboticsSeptember 21, 2018$1.64 b
Visionsense LtdApril 11, 2018$75 m
CrosponDecember 10, 2017
HeartWare InternationalJune 27, 2016$1.10 b
Responsive OrthopedicsJune 07, 2016
Smith & Nephew's gynecology businessMay 18, 2016$350 m
BellcoFebruary 02, 2016
Aircraft MedicalNovember 18, 2015$110 m
Show more

Medtronic Revenue Breakdown

Embed Graph

Medtronic revenue breakdown by business segment: 7.1% from Diabetes Group, 25.9% from Restorative Therapies Group, 37.9% from Cardiac and Vascular Group and 29.1% from Minimally Invasive Therapies Group

Medtronic revenue breakdown by geographic segment: 46.7% from Rest of World, 53.0% from United States and 0.3% from Other

Human Capital Metrics

Source: www.medtronic.com, www.medtronic.com
Embed Graph
Show all human capital metrics
Report incorrect company information

Competitors

Ra Medical Systems
Healthcare - Public
Olympus Corporation
Manufacturing & Industrial - Public
Nikkiso
Manufacturing & Industrial - Public
Boston Scientific
Healthcare - Public
Stryker
Healthcare - Public
St. Jude Medical
Healthcare - Subsidiary
Compare competitors

Medtronic Online and Social Media Presence

Embed Graph
Report incorrect company information

Medtronic News and Updates

March 17, 2019

New Clinical Trial Shows Medtronic TYRX(TM) Envelope Signficantly Reduces Major Infections in Cardiac Implantable Device Patients

March 16, 2019

Medtronic Evolut Low Risk Trial Meets Primary Endpont

March 16, 2019

Edwards, Medtronic heart valve systems prove worth in low-risk patients -studies

Non-invasive heart valve replacement systems from Medtronic Plc and rival Edwards Lifesciences Corp proved as good or better than open heart surgery in younger, more active patients for whom the surgical option was deemed low risk, according to trial results presented on Saturday.
March 15, 2019

Global Vital Sign Monitoring Market Outlook, 2019 to 2024 with A&D Medical, Hill-Rom, Nihon Kohden, Koninklijke Philips, and Medtronic Dominating

DUBLIN, March 15, 2019 /PRNewswire/ -- The "Vital Sign Monitoring Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering. The global vital sign monitoring market was valued at USD 4,413.53 million in 2018, and is estimated to be...
March 14, 2019

Medtronic Board Appoints Andrea J. Goldsmith, Ph.D. as a New Director

March 08, 2019

Medtronic board approves $6 billion more in stock buybacks

Medtronic PLC said late Friday its board authorized a new plan to buy back up to $6 billion in shares. Prior to the new plan, the medical device company said it has $1.3 billion in share buyback authorization left in a $5 billion plan approved in June 2017. Shares of Medtronic ticked 1% higher in t…
Show more
Report incorrect company information

 Medtronic Frequently Asked Questions

  • When was Medtronic founded?

    Medtronic was founded in 1949.

  • Who are Medtronic key executives?

    Medtronic's key executives are Omar Ishrak, Karen Parkhill and Richard Kuntz.

  • How many employees does Medtronic have?

    Medtronic has 86,000 employees.

  • What is Medtronic revenue?

    Latest Medtronic annual revenue is $30 b.

  • What is Medtronic revenue per employee?

    Latest Medtronic revenue per employee is $348.3 k.

  • Who are Medtronic competitors?

    Competitors of Medtronic include Ra Medical Systems, Olympus Corporation and Nikkiso.

  • Where is Medtronic headquarters?

    Medtronic headquarters is located at 710 Medtronic Pkwy NE, Minneapolis.

  • Where are Medtronic offices?

    Medtronic has offices in Minneapolis, Tampa, Sunnyvale, Santa Rosa and in 83 other locations.

  • How many offices does Medtronic have?

    Medtronic has 95 offices.

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Learn more